Skip pattern approach toward the early access of innovative anticancer drugs

BACKGROUND: With the rapid development of innovative anticancer treatments, the optimization of tools able to accelerate the access of new drugs to the market by the regulatory authority is a major issue. The aim of the project was to propose a reliable methodological pathway for the assessment of c...

Descripción completa

Detalles Bibliográficos
Autores principales: Apolone, G., Ardizzoni, A., Biondi, A., Bortolami, A., Cardone, C., Ciniselli, C.M., Conte, P., Crippa, C., de Braud, F., Duca, M., Gori, S., Gritti, G., Inno, A., Luksch, R., Lussana, F., Maio, M., Pasello, G., Perrone, F., Rambaldi, A., Rossi, G., Signorelli, D., Soverini, G., Valente, M., Verderio, P., Buzzetti, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350180/
https://www.ncbi.nlm.nih.gov/pubmed/34352703
http://dx.doi.org/10.1016/j.esmoop.2021.100227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350180/
https://www.ncbi.nlm.nih.gov/pubmed/34352703
http://dx.doi.org/10.1016/j.esmoop.2021.100227

Ejemplares similares